These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Advance in herpes simplex viruses for cancer therapy. Liu S; Dai M; You L; Zhao Y Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184 [TBL] [Abstract][Full Text] [Related]
8. Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges. Liu H; Luo H Viruses; 2021 Jun; 13(6):. PubMed ID: 34198859 [TBL] [Abstract][Full Text] [Related]
9. Viral cancer therapies: are they ready for combination with other immunotherapies? Boisgerault N; Grégoire M; Fonteneau JF Future Oncol; 2017 Aug; 13(18):1569-1571. PubMed ID: 28776392 [No Abstract] [Full Text] [Related]
10. MRI Scanners Guide Therapy to Tumors. Cancer Discov; 2015 Nov; 5(11):OF3. PubMed ID: 26370155 [TBL] [Abstract][Full Text] [Related]
11. [Genetic, immunological, and pharmacological strategies to generate improved oncolytic viruses]. Pol J; Le Bœuf F; Diallo JS Med Sci (Paris); 2013 Feb; 29(2):165-73. PubMed ID: 23452603 [TBL] [Abstract][Full Text] [Related]
13. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus. Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533 [TBL] [Abstract][Full Text] [Related]
14. Capsid Engineering of Adenovirus Vectors: Overcoming Early Vector-Host Interactions for Therapy. Hagedorn C; Kreppel F Hum Gene Ther; 2017 Oct; 28(10):820-832. PubMed ID: 28854810 [TBL] [Abstract][Full Text] [Related]
15. Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy. Hiss DC; Fielding BC Expert Opin Biol Ther; 2012 Nov; 12(11):1427-47. PubMed ID: 22788715 [TBL] [Abstract][Full Text] [Related]
16. The promise of microbial engineering for developing new strategies for tackling human disease. López-Goñi I Future Microbiol; 2012 Feb; 7(2):167-9. PubMed ID: 22324983 [No Abstract] [Full Text] [Related]
17. Oncolytic viruses: now interviewing for the all-star game. Vile R Mol Ther; 2010 May; 18(5):866-8. PubMed ID: 20436492 [No Abstract] [Full Text] [Related]
19. Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models. Terada K; Wakimoto H; Tyminski E; Chiocca EA; Saeki Y Gene Ther; 2006 Apr; 13(8):705-14. PubMed ID: 16421599 [TBL] [Abstract][Full Text] [Related]
20. Oncolytic HSV as a vector in cancer immunotherapy. Li H; Zhang X Methods Mol Biol; 2010; 651():279-90. PubMed ID: 20686972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]